دورية أكاديمية
Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis.
| العنوان: | Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis. |
|---|---|
| المؤلفون: | De Mutiis C; Paediatric Unit, Maggiore Hospital, Azienda USL, Bologna, Italy. chiarademutiis@yahoo.com., Wenderfer SE; Pediatric Nephrology, The University of British Columbia, BC Children's Hospital, Vancouver, BC, Canada., Basu B; Division of Pediatric Nephrology, Department of Pediatrics, Nilratan Sircar Medical College and Hospital, Kolkata, India., Bagga A; Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India., Orjuela A; Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA., Sar T; Division of Pediatric Nephrology, Department of Pediatrics, Nilratan Sircar Medical College and Hospital, Kolkata, India., Aggarwal A; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India., Jain A; Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.; Department of Clinical Immunology and Rheumatology, Sawai Mansingh Medical College, Jaipur, India., Boyer O; Pediatric Nephrology, Necker Enfants Malades Hospital, Université Paris Cité, Paris, France.; Néphrologie Pédiatrique, Hôpital Necker, Paris, France., Yap HK; Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Ito S; Department of Pediatrics, Yokohama City University, Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan., Ohnishi A; Department of Pediatrics, Yokohama City University, Fukuura, Kanazawa-Ku, Yokohama, Kanagawa, Japan., Iwata N; Department of Infection and Immunology, Aichi Children's Health and Medical Center, Obu, Japan., Kasapcopur O; Department of Pediatric Rheumatology, Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Istanbul, Turkey., Laurent A; Department of Pediatric Nephrology, Rheumatology and Dermatology, Hospices Civils de Lyon, Lyon, France., Chan EY; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR.; Department of Paediatrics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR., Mastrangelo A; Pediatric Nephrology, Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy., Ogura M; Division of Nephrology and Rheumatology, National Center for Child Health and Development, Tokyo, Japan., Shima Y; Department of Pediatrics, Wakayama Medical University, Wakayama, Japan., Rianthavorn P; Division of Nephrology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Silva CA; Pediatric Rheumatology Unit, Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Trindade V; Pediatric Rheumatology Unit, Children's Institute, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil., Tullus K; Paediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. |
| المصدر: | Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2024 Oct; Vol. 39 (10), pp. 2959-2968. Date of Electronic Publication: 2024 May 28. |
| نوع المنشور: | Journal Article; Multicenter Study |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Berlin : Springer International Original Publication: Berlin : Springer International, c1987- |
| مواضيع طبية MeSH: | Lupus Nephritis*/blood , Lupus Nephritis*/diagnosis , Biomarkers*/blood , Glomerular Filtration Rate*, Humans ; Child ; Female ; Male ; Retrospective Studies ; Adolescent ; Blood Sedimentation ; Remission Induction ; Kidney/pathology ; Kidney/physiopathology ; Complement C3/analysis ; Complement C3/metabolism ; Antibodies, Antinuclear/blood ; Proteinuria/etiology ; Proteinuria/urine ; Proteinuria/blood ; Proteinuria/diagnosis ; Complement C4/analysis ; Complement C4/metabolism ; Child, Preschool |
| مستخلص: | Background: Lupus nephritis (LN) is a very severe manifestation of lupus. There is no consensus on which treatment goals should be achieved to protect kidney function in children with LN. Methods: We retrospectively analyzed trends of commonly used laboratory biomarkers of 428 patients (≤ 18 years old) with biopsy-proven LN class ≥ III. We compared data of patients who developed stable kidney remission from 6 to 24 months with those who did not. Results: Twenty-five percent of patients maintained kidney stable remission while 75% did not. More patients with stable kidney remission showed normal hemoglobin and erythrocyte sedimentation rate from 6 to 24 months compared to the group without stable kidney remission. eGFR ≥ 90 ml/min/1.73m 2 at onset predicted the development of stable kidney remission (93.8%) compared to 64.7% in those without stable remission (P < 0.00001). At diagnosis, 5.9% and 20.2% of the patients showed no proteinuria in the group with and without stable kidney remission, respectively (P = 0.0001). dsDNA antibodies decreased from onset of treatment mainly during the first 3 months in all groups, but more than 50% of all patients in both groups never normalized after 6 months. Complement C3 and C4 increased mainly in the first 3 months in all patients without any significant difference. Conclusions: Normal eGFR and the absence of proteinuria at onset were predictors of stable kidney remission. Significantly more children showed normal levels of Hb and erythrocyte sedimentation rate (ESR) from 6 to 24 months in the group with stable kidney remission. (© 2024. The Author(s), under exclusive licence to International Pediatric Nephrology Association.) |
| References: | Tektonidou MG, Lewandowski LB, Hu J, Dasgupta A, Ward MM (2017) Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis 76:2009–2016. (PMID: 10.1136/annrheumdis-2017-21166328794077) Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C et al (2002) Longterm follow up of childhood lupus nephritis. J Rheumatol 29:2635–2642. (PMID: 12465165) Chan EY, Yap DY, Wong WT, Wong WH, Wong SW, Lin KY, Hui FY, Yee-Ming J, Lam SS, Wong JK, Lai FF, Ho TW, Tong PC, Lai WM, Chan TM, Ma AL (2022) Long-term outcomes of children and adolescents with biopsy-proven childhood-onset lupus nephritis. Kidney Int Rep 8:141–150. https://doi.org/10.1016/j.ekir.2022.10.014. (PMID: 10.1016/j.ekir.2022.10.014366443609831948) Suhlrie A, Hennies I, Gellermann J, Büscher A, Hoyer P, Waldegger S et al (2020) Twelve-month outcome in juvenile proliferative lupus nephritis: results of the German registry study. Pediatr Nephrol 35:1235–1246. https://doi.org/10.1007/s00467-020-04501-x. (PMID: 10.1007/s00467-020-04501-x32193650) Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B et al (2017) European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis 76:1965–1973. (PMID: 10.1136/annrheumdis-2017-21189828877866) Franklyn K, Lau CS, Navarra SV, Louthrenoo W, Lateef A, Hamijoyo L, Wahono CS, Chen SL, Jin O, Morton S, Hoi A, Huq M, Nikpour M, Morand EF (2016) Asia-Pacific Lupus Collaboration. Definition and initial validation of a Lupus Low Disease Activity State (LLDAS). Ann Rheum Dis 75:1615–1621. https://doi.org/10.1136/annrheumdis-2015-207726. (PMID: 10.1136/annrheumdis-2015-20772626458737) De Mutiis C, Wenderfer SE, Orjuela A, Bagga A, Basu B, Sar T, Aggarwal A, Jain A, Yap HK, Ito S, Ohnishi A, Iwata N, Kasapcopur O, Laurent A, Mastrangelo A, Ogura M, Shima Y, Rianthavorn P, Silva CA, Trindade V, Dormi A, Tullus K (2022) Defining renal remission in an international cohort of 248 children and adolescents with lupus nephritis. Rheumatology (Oxford) 61:2563–2571. https://doi.org/10.1093/rheumatology/keab746. (PMID: 10.1093/rheumatology/keab74634626102) Bajema IM, Wilhelmus S, Alpers CE, Bruijn JA, Colvin RB, Cook HT et al (2018) Revision of the international society of nephrology/renal pathology society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int 93:789–796. (PMID: 10.1016/j.kint.2017.11.02329459092) Marks SD, Pilkington C, Woo P, Dillon MJ (2004) The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology 43:1186–1189. (PMID: 10.1093/rheumatology/keh28415226518) Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640. (PMID: 10.1002/art.17803506061599520) Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287. (PMID: 10.1681/ASN.2008030287191583562653687) Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372–376. https://doi.org/10.3109/14397595.2015.1091136. (PMID: 10.3109/14397595.2015.109113626403379) Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026–11031. (PMID: 263799004565283) Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA (2020) Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed) 16:255–261. https://doi.org/10.1016/j.reuma.2018.07.008. (PMID: 10.1016/j.reuma.2018.07.00830166230) Wu Y, Chen Y, Yang X, Chen L, Yang Y (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 36:94–99. https://doi.org/10.1016/j.intimp.2016.04.006. (PMID: 10.1016/j.intimp.2016.04.00627111516) Firooz N, Albert DA, Wallace DJ, Ishimori M, Berel D, Weisman MH (2011) High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus. Lupus 20:588–597. https://doi.org/10.1177/0961203310393378. (PMID: 10.1177/096120331039337821436216) Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD (2005) LUMINA Study Group. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual. J Rheumatol 32:2150–2155. (PMID: 16265693) Gordon C, Amissah-Arthur MB, Gayed M, Brown S, Bruce IN, D’Cruz D, Empson B, Griffiths B, Jayne D, Khamashta M, Lightstone L, Norton P, Norton Y, Schreiber K, Isenberg D (2018) British society for rheumatology standards, audit and guidelines working group. The British society for rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology (Oxford) 57:e1–e45. https://doi.org/10.1093/rheumatology/kex286. (PMID: 10.1093/rheumatology/kex28629029350) Abdelrahman N, Beresford MW, Leone V (2019) UK Juvenile-onset Systemic Lupus Erythematosus Study Group. Challenges of achieving clinical remission in a national cohort of juvenile-onset systemic lupus erythematosus patients. Lupus 28:667–674. https://doi.org/10.1177/0961203319840699. (PMID: 10.1177/096120331984069930943853) Mirzayan MJ, Schmidt RE, Witte T (2000) Prognostic parameters for flare in systemic lupus erythematosus. Rheumatology (Oxford) 39:1316–1319. https://doi.org/10.1093/rheumatology/39.12.1316. (PMID: 10.1093/rheumatology/39.12.131611136872) Petri M, Singh S, Tesfasyone H, Malik A (2009) Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: a prospective study. J Rheumatol 36:2476–2480. https://doi.org/10.3899/jrheum.090019. (PMID: 10.3899/jrheum.09001919833757) Moroni G, Radice A, Giammarresi G, Quaglini S, Gallelli B, Leoni A, Li Vecchi M, Messa P, Sinico RA (2009) Are laboratory tests useful for monitoring the activity of lupus nephritis? A 6-year prospective study in a cohort of 228 patients with lupus nephritis. Ann Rheum Dis 68:234–237. https://doi.org/10.1136/ard.2008.094508. (PMID: 10.1136/ard.2008.09450818718989) Hajji M, Harzallah A, Kaaroud H, Barbouch S, Hamida FB, Abdallah TB (2017) Factors associated with relapse of lupus nephritis: a single center study of 249 cases. Saudi J Kidney Dis Transpl 28:1349–1355. https://doi.org/10.4103/1319-2442.220863. (PMID: 10.4103/1319-2442.22086329265046) Bertsias GK, Salmon JE, Boumpas DT (2010) Therapeutic opportunities in systemic lupus erythematosus: state of the art and prospects for the new decade. Ann Rheum Dis 69:1603–1611. https://doi.org/10.1136/ard.2010.135186. (PMID: 10.1136/ard.2010.13518620699243) Birmingham DJ, Irshaid F, Nagaraja HN, Zou X, Tsao BP, Wu H, Yu CY, Hebert LA, Rovin BH (2010) The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus 19:1272–1280. https://doi.org/10.1177/0961203310371154. (PMID: 10.1177/0961203310371154206058793086056) Manson JJ, Ma A, Rogers P, Mason LJ, Berden JH, van der Vlag J, D’Cruz DP, Isenberg DA, Rahman A (2009) Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study. Arthritis Res Ther 11:R154. https://doi.org/10.1186/ar2831. (PMID: 10.1186/ar2831198280472787270) Van Vollenhoven RF, Bertsias G, Doria A, Isenberg D, Morand E, Petri MA, Pons-Estel BA, Rahman A, Ugarte-Gil MF, Voskuyl A, Arnaud L, Bruce IN, Cervera R, Costedoat-Chalumeau N, Gordon C, Houssiau FA, Mosca M, Schneider M, Ward MM, Alarcon G, Aringer M, Askenase A, Bae SC, Bootsma H, Boumpas DT, Brunner H, Clarke AE, Coney C, Czirják L, Dörner T, Faria R, Fischer R, Fritsch-Stork R, Inanc M, Jacobsen S, Jayne D, Kuhn A, van Leeuw B, Limper M, Mariette X, Navarra S, Nikpour M, Olesinska MH, Pons-Estel G, Romero-Diaz J, Rubio B, Schoenfeld Y, Bonfá E, Smolen J, Teng YKO, Tincani A, Tsang-A-Sjoe M, Vasconcelos C, Voss A, Werth VP, Zakharhova E, Aranow C (2021) 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Sci Med 8:e000538. https://doi.org/10.1136/lupus-2021-000538. (PMID: 10.1136/lupus-2021-000538348193888614136) Dall’Era M, Cisternas MG, Smilek DE, Straub L, Houssiau FA, Cervera R, Rovin BH, Mackay M (2015) Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort. Arthritis Rheumatol 67:1305–1313. https://doi.org/10.1002/art.39026. (PMID: 10.1002/art.3902625605554) Zappitelli M, Duffy CM, Bernard C, Gupta IR (2008) Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis. Pediatr Nephrol 23:83–91. https://doi.org/10.1007/s00467-007-0619-7. (PMID: 10.1007/s00467-007-0619-717957388) Moroni G, Gatto M, Tamborini F, Quaglini S, Radice F, Saccon F, Frontini G, Alberici F, Sacchi L, Binda V, Trezzi B, Vaglio A, Messa P, Sinico RA, Doria A (2020) Lack of EULAR/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis. Ann Rheum Dis 79:1077–1083. https://doi.org/10.1136/annrheumdis-2020-216965. (PMID: 10.1136/annrheumdis-2020-21696532503858) González Celedón C, Bitsori M, Tullus K (2007) Progression of chronic renal failure in children with dysplastic kidneys. Pediatr Nephrol 22:1014–1020. https://doi.org/10.1007/s00467-007-0459-5. (PMID: 10.1007/s00467-007-0459-517380351) Wingen AM, Fabian-Bach C, Schaefer F, Mehls O (1997) Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet 349:1117–1123. https://doi.org/10.1016/s0140-6736(96)09260-4. (PMID: 10.1016/s0140-6736(96)09260-49113009) Wühl E, Schnaper HW (2021) Progression of chronic kidney disease and nephroprotection in children. In: Emma F, Goldstein S, Bagga A, Bates CM, Shroff R (eds) Pediatric Nephrology. Springer, Berlin, Heidelberg, pp 1679–1700. Chan EY, Ma AL, Tullus K (2021) When should we start and stop ACEi/ARB in paediatric chronic kidney disease? Pediatr Nephrol 36:1751–1764. https://doi.org/10.1007/s00467-020-04788-w. (PMID: 10.1007/s00467-020-04788-w33057769) Provenzano M, Puchades MJ, Garofalo C, Jongs N, D’Marco L, Andreucci M, De Nicola L, Gorriz JL, Heerspink HJL (2022) ROTATE-3 study group; ROTATE-3 study group members. Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: a randomized crossover clinical trial. J Am Soc Nephrol 33:1569–1580. https://doi.org/10.1681/ASN.2022020207. (PMID: 10.1681/ASN.2022020207354405019342643) |
| فهرسة مساهمة: | Keywords: Biomarkers; Lupus nephritis; Pediatric; Proteinuria; Remission; eGFR |
| المشرفين على المادة: | 0 (Biomarkers) 0 (Complement C3) 0 (Antibodies, Antinuclear) 0 (Complement C4) |
| تواريخ الأحداث: | Date Created: 20240527 Date Completed: 20240827 Latest Revision: 20240827 |
| رمز التحديث: | 20240828 |
| DOI: | 10.1007/s00467-024-06405-6 |
| PMID: | 38802607 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 1432-198X |
|---|---|
| DOI: | 10.1007/s00467-024-06405-6 |